Sabra Health Care REIT, Inc.
SBRA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $703,235 | $647,514 | $624,811 | $569,545 |
| % Growth | 8.6% | 3.6% | 9.7% | – |
| Cost of Goods Sold | $227,088 | $195,245 | $162,613 | $141,201 |
| Gross Profit | $476,147 | $452,269 | $462,198 | $428,344 |
| % Margin | 67.7% | 69.8% | 74% | 75.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $50,067 | $47,472 | $39,574 | $34,669 |
| SG&A Expenses | $50,067 | $47,472 | $39,574 | $34,669 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $169,052 | $183,087 | $187,782 | $182,926 |
| Operating Expenses | $219,119 | $230,559 | $227,356 | $217,595 |
| Operating Income | $257,028 | $221,710 | $234,842 | $210,749 |
| % Margin | 36.5% | 34.2% | 37.6% | 37% |
| Other Income/Exp. Net | -$129,311 | -$205,952 | -$311,205 | -$322,160 |
| Pre-Tax Income | $127,717 | $15,758 | -$76,363 | -$111,411 |
| Tax Expense | $1,005 | $2,002 | $1,242 | $1,845 |
| Net Income | $126,712 | $13,756 | -$77,605 | -$113,256 |
| % Margin | 18% | 2.1% | -12.4% | -19.9% |
| EPS | 0.54 | 0.06 | -0.34 | -0.52 |
| % Growth | 807.6% | 117.5% | 34.6% | – |
| EPS Diluted | 0.54 | 0.059 | -0.34 | -0.52 |
| Weighted Avg Shares Out | 233,499 | 231,203 | 230,948 | 219,073 |
| Weighted Avg Shares Out Dil | 236,046 | 232,793 | 230,948 | 219,073 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $115,272 | $112,964 | $105,471 | $98,632 |
| Depreciation & Amortization | $169,623 | $183,087 | $187,782 | $178,991 |
| EBITDA | $412,612 | $311,809 | $216,890 | $166,212 |
| % Margin | 58.7% | 48.2% | 34.7% | 29.2% |